Sandoz Launches Mometasone Nasal Spray In Slovenia

Sandoz (Novartis) has launched its mometasone nasal spray in Slovenia. The product is indicated for the treatment of seasonal or perennial allergy rhinitis and symptomatic treatment of nasal polyps. Sandoz commented that it is the first to market a generic mometasone nasal spray in the country. The firm added that the product has already been approved in more than 20 EU countries, and has been launched in Poland, the Czech Republic, Slovakia and Romania.

This article is tagged to:
Sector: Pharmaceuticals & Healthcare, Medical Devices
Geography: Slovenia

Access all of our latest analysis, data and forecasts - request a trial